CN103202506B - 一种提神醒脑植物饮料及其生产方法 - Google Patents
一种提神醒脑植物饮料及其生产方法 Download PDFInfo
- Publication number
- CN103202506B CN103202506B CN201310151595.6A CN201310151595A CN103202506B CN 103202506 B CN103202506 B CN 103202506B CN 201310151595 A CN201310151595 A CN 201310151595A CN 103202506 B CN103202506 B CN 103202506B
- Authority
- CN
- China
- Prior art keywords
- sucrose
- beverage
- mind
- chrysanthemum
- seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000694 effects Effects 0.000 title claims abstract description 43
- 235000013361 beverage Nutrition 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000000463 material Substances 0.000 claims abstract description 25
- 241000196324 Embryophyta Species 0.000 claims abstract description 23
- 229930006000 Sucrose Natural products 0.000 claims abstract description 21
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 21
- 239000005720 sucrose Substances 0.000 claims abstract description 21
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 20
- 241001165494 Rhodiola Species 0.000 claims abstract description 20
- 241000110637 Cuscuta chinensis Species 0.000 claims abstract description 19
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 18
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 18
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 18
- 240000000249 Morus alba Species 0.000 claims abstract description 18
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 18
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 18
- 238000009835 boiling Methods 0.000 claims abstract description 11
- 239000000706 filtrate Substances 0.000 claims abstract description 10
- 230000001954 sterilising effect Effects 0.000 claims abstract description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 8
- 238000011049 filling Methods 0.000 claims abstract description 5
- 239000006286 aqueous extract Substances 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 241000723353 Chrysanthemum Species 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 8
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 23
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 239000003814 drug Substances 0.000 description 13
- 230000009182 swimming Effects 0.000 description 12
- 239000012141 concentrate Substances 0.000 description 11
- 102100026189 Beta-galactosidase Human genes 0.000 description 10
- 108010059881 Lactase Proteins 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 108010005774 beta-Galactosidase Proteins 0.000 description 10
- 229940116108 lactase Drugs 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000013074 reference sample Substances 0.000 description 7
- 229920002527 Glycogen Polymers 0.000 description 6
- 229940096919 glycogen Drugs 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 230000002929 anti-fatigue Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 230000002440 hepatic effect Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 231100000460 acute oral toxicity Toxicity 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000009661 fatigue test Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000007666 subchronic toxicity Effects 0.000 description 1
- 231100000195 subchronic toxicity Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310151595.6A CN103202506B (zh) | 2013-04-27 | 2013-04-27 | 一种提神醒脑植物饮料及其生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310151595.6A CN103202506B (zh) | 2013-04-27 | 2013-04-27 | 一种提神醒脑植物饮料及其生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103202506A CN103202506A (zh) | 2013-07-17 |
CN103202506B true CN103202506B (zh) | 2015-08-19 |
Family
ID=48750089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310151595.6A Active CN103202506B (zh) | 2013-04-27 | 2013-04-27 | 一种提神醒脑植物饮料及其生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103202506B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105918567A (zh) * | 2016-05-24 | 2016-09-07 | 安徽省康隆农业科技有限公司 | 一种生津止渴菊花茶及其制作方法 |
CN106173649A (zh) * | 2016-07-05 | 2016-12-07 | 张红 | 一种抗疲劳的保健饮品及其制备方法 |
CN111802551A (zh) * | 2020-08-18 | 2020-10-23 | 唐山曹妃甸恒瑞海洋生物科技产业有限公司 | 一种健康长效提神饮料 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1593611A (zh) * | 2004-06-18 | 2005-03-16 | 葛永 | 一种具有养目明目、有益于改善视力的营养食品 |
KR100522621B1 (ko) * | 2004-12-14 | 2005-10-18 | 충청북도 | 두충을 함유하는 두충음료 |
CN102224964A (zh) * | 2011-05-09 | 2011-10-26 | 常堡同 | 提神健脑饮料 |
CN102551161A (zh) * | 2012-02-03 | 2012-07-11 | 湖北武当生物医药科技有限公司 | 一种含金银花和鱼腥草的植物饮料配方及生产方法 |
-
2013
- 2013-04-27 CN CN201310151595.6A patent/CN103202506B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1593611A (zh) * | 2004-06-18 | 2005-03-16 | 葛永 | 一种具有养目明目、有益于改善视力的营养食品 |
KR100522621B1 (ko) * | 2004-12-14 | 2005-10-18 | 충청북도 | 두충을 함유하는 두충음료 |
CN102224964A (zh) * | 2011-05-09 | 2011-10-26 | 常堡同 | 提神健脑饮料 |
CN102551161A (zh) * | 2012-02-03 | 2012-07-11 | 湖北武当生物医药科技有限公司 | 一种含金银花和鱼腥草的植物饮料配方及生产方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103202506A (zh) | 2013-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8778410B2 (en) | Oral or enteral composition useful for recovery of physical functions | |
CN102349675A (zh) | 一种红参饮料及其制作方法 | |
CN107637743A (zh) | 无糖型桑叶颗粒固体饮料及其制备方法 | |
CN101637265B (zh) | 一种用于改善睡眠的保健食品 | |
CN103202506B (zh) | 一种提神醒脑植物饮料及其生产方法 | |
CN104388236A (zh) | 一种葡萄酒及其制备方法与应用 | |
CN105861224A (zh) | 石斛养生酒及其制备方法 | |
CN101711840B (zh) | 一种适用于癌症患者的药食两用组合物及其制备方法 | |
CN103725555A (zh) | 一种辅助降血压的野生芭蕉及牛角蕉保健酒及其制备方法 | |
CN105433382B (zh) | 一种玛咖组合物及其制备方法和用途 | |
KR101859166B1 (ko) | 인삼이 함유된 한약재 추출물을 유효성분으로 함유하는 숙취 해소용 조성물 | |
CN106236927A (zh) | 一种具有增强免疫力和抗疲劳作用的中药组合物及其制备方法与用途 | |
CN101721403A (zh) | 岩藻黄素在减肥方面的应用 | |
CN104026568B (zh) | 一种保健品组合物 | |
US10595547B2 (en) | Solid drink for regulating qi-depression constitution and processing method thereof | |
CN101062326A (zh) | 一种具有抗疲劳作用的中药组合物 | |
CN102784230B (zh) | 一种治疗营养性贫血的药物组合物制剂 | |
CN105639497A (zh) | 一种海参火腿肠的配方及其加工工艺 | |
CN106929363B (zh) | 一种保健酒剂及其制备方法 | |
CN107012057A (zh) | 一种耐缺氧保健酒及其制备方法 | |
CN106109866B (zh) | 一种用于缓解痛经的口服液及其制备方法 | |
CN108433108A (zh) | 一种六红素制剂及其制备方法 | |
CN101143203B (zh) | 一种具有护肝养胃功能的复方口服液 | |
CN107281390A (zh) | 一种用于养生保健的中药组合物及其制备方法 | |
CN105838546A (zh) | 石斛保健酒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LI ZHAN Free format text: FORMER OWNER: YANG LU Effective date: 20150721 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Lu Inventor after: Li Zhan Inventor after: Liu Shouzhi Inventor before: Yang Lu |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YANG LU TO: YANG LU LI ZHAN LIU SHOUZHI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150721 Address after: Luxi Gulou District of Nanjing city in Jiangsu province 210037 Camp No. 97 Jinmao garden 10 Building 2 unit 702 room Applicant after: Li Zhan Address before: 100810 Beijing city Xicheng District North Road No. 38 State Drug Administration Applicant before: Yang Lu |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Li Zhan Document name: Notification that Application Deemed not to be Proposed |
|
CB03 | Change of inventor or designer information |
Inventor after: Yang Lu Inventor after: Li Zhan Inventor after: Liu Shouzhi Inventor after: Li Yuxian Inventor after: Bian Junxing Inventor after: Yu Qiuyang Inventor after: Chen Xingyue Inventor before: Yang Lu Inventor before: Li Zhan Inventor before: Liu Shouzhi |
|
COR | Change of bibliographic data | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Lu Inventor after: Li Zhan Inventor after: Liu Shouzhi Inventor after: Li Yuxian Inventor after: Bian Junxing Inventor after: Yu Qiuyang Inventor before: Yang Lu Inventor before: Li Zhan Inventor before: Liu Shouzhi Inventor before: Li Yuxian Inventor before: Bian Junxing Inventor before: Yu Qiuyang Inventor before: Chen Xingyue |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160819 Address after: Longmian road Jiangning District of Nanjing City, Jiangsu province 211112 No. 568 No. 1 Building 5 layer Patentee after: NANJING JIQUN PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO.,LIMITED Address before: Luxi Gulou District of Nanjing city in Jiangsu province 210037 Camp No. 97 Jinmao garden 10 Building 2 unit 702 room Patentee before: Li Zhan |
|
CP01 | Change in the name or title of a patent holder |
Address after: Longmian road Jiangning District of Nanjing City, Jiangsu province 211112 No. 568 No. 1 Building 5 layer Patentee after: Nanjing Ji medicine Polytron Technologies Inc Address before: Longmian road Jiangning District of Nanjing City, Jiangsu province 211112 No. 568 No. 1 Building 5 layer Patentee before: NANJING JIQUN PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO.,LIMITED |
|
CP01 | Change in the name or title of a patent holder |